| ? | ||||||||||||
|
||||||||||||
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
| 購買進(jìn)口儀器、試劑和耗材——就在始于2001年的畢特博生物 www.effectnews.cn |
產(chǎn)品中文名稱：X-VIVO™ 15化學(xué)成分確定的無血清造血干細(xì)胞培養(yǎng)基
LONZA 04-418Q X-VIVO™ Chemically Defined, Serum-free Hematopoietic Cell Medium 研究背景 Lonza’s R&D efforts and collaboration with many clinical trials have provided Lonza with the tools and expertise to support the developments in adoptive immunotherapy, cancer therapy, genetic therapy and other cellular therapies. Lonza’s philosophy for the development of serum-free formulations for use in cellular therapy is to provide a nutritionally complete and balanced environment for the cells. We have not included any exogenous growth factors, artificial stimulators of cellular proliferation or undefined supplements. The products LONZA 04-418Q X-VIVO 15 are devoid of any protein-kinase C stimulators and are suitable for the investigation of second messenger systems in the activation of human and murine lymphocytes. The formulations are complete and contain pharmaceutical grade human albumin, recombinant human insulin and pasteurized human transferrin. All X-VIVO™ Medium products are manufactured under current GMPs and are listed with the FDA in a product Master File. Permission to cross-reference the Master File may be obtained by contacting the Product Manager. LONZA X-VIVO™ 15 Chemically Defined, Serum-free Hematopoietic Cell Medium 簡介 X-VIVO™ 20 Medium was developed and optimized to support the generation of LAK cells from monocyte-depleted PBL at high density. Initial cell densities between 2.0- 3.0 x 107 cells/ml were successfully used to generate LAK cells. X-VIVO™ Medium 20 may also be used as a growth medium for PBL and TIL. LONZA X-VIVO™ 15化學(xué)成分確定的無血清造血細(xì)胞培養(yǎng)基特點(diǎn) » 不含血清 » 化學(xué)成份明確 » 成份包含L-谷氨酰胺，慶大霉素和酚紅 » LONZA 04-418Q 最適于無血清環(huán)境中腫瘤浸潤淋巴細(xì)胞(TIL)增殖 X-VIVO™ 15 Chemically Defined, Serum-free Hematopoietic Cell Medium 使用注意事項(xiàng) 1. LONZA 04-418Q X-VIVO™ 15 is similar in composition to X-VIVO™ 10 and has been optimized for the proliferation of Tumor Infiltrating Lymphocytes (TIL) under serum-free conditions. 2.Please see Supplemental Information for additional hematopoietic cell applications. 3.X-VIVO™ 15, catalog number 04-418 is formulated with L-glutamine, gentamicin, and phenol red. Catalog number 04-744Q contains L-glutamine but does not contain gentamicin or phenol red. 4.X-VIVO™ 15, catalog number BE02-053Q is formulated with L-glutamine, gentamicin, recombinant transferrin, and phenol red. X-VIVO™ 15, catalog number BE02-054Q, contains L-glutamine and recombinant transferrin but does not contain gentamicin or phenol red. The recombinant transferrin replaces native transferrin. Lonza X-VIVO™ 化學(xué)成分確定的無血清造血干細(xì)胞培養(yǎng)基訂購信息 Catalog Number Description Size LONZA 04-380Q X-VIVO™ 10 Medium with L-glutamine, gentamicin, 1 L and phenol red LONZA 04-743Q X-VIVO™ 10 Medium with L-glutamine; without 1 L gentamicin or phen red LONZA BE04-418F X-VIVO™ 15 Medium with L-glutamine, gentamicin, 500ml and phenol red (Europe only) LONZA 04-418Q X-VIVO™ 15 Medium with L-glutamine, gentamicin, 1 L and phenol red 04-744Q X-VIVO™ 15 Medium with L-glutamine; without 1 L gentamicin orphenol red 04-448Q X-VIVO™ 20 Medium with L-glutamine, gentamicin, 1 L and phenol red
北京畢特博生物技術(shù)有限責(zé)任公司 http://www.effectnews.cn
lonza無血清培養(yǎng)基 網(wǎng)址鏈接http://www.effectnews.cn/a/gb2312/gongsixinxi/shichanghuodong/2013/0331/5024.html lonza 04-418Q無血清培養(yǎng)基 網(wǎng)址鏈接http://www.effectnews.cn/a/gb2312/info/2013/0413/5029.html lonza 12-725F無血清培養(yǎng)基 網(wǎng)址鏈接http://bitebo.com/a/gb2312/gongsixinxi/shichanghuodong/2014/0514/5157.html
始于1994年的畢特博生物（畢龍轉(zhuǎn)基因http://www.bilong.com）于1994年就與LONZA（原Cambrex）合作，一直被授權(quán)代理Lonza產(chǎn)品，是中國大陸第一家LONZA代理商，畢特博生物一直與Lonza公司攜手開拓中國市場公司，現(xiàn)已成為生物技術(shù)領(lǐng)域的佼佼者,也將Lonza公司的理念貫徹到底，打造生物技術(shù)新概念。
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
購買進(jìn)口儀器、試劑和耗材——就在始于2001年的畢特博生物
www.effectnews.cn |
|
